ScholarIQanswers from OpenAlex & ORCID
Arthur I. Sagalowsky
ResearcherPublications, citations & collaboration network
Arthur I. Sagalowsky is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Arthur I. Sagalowsky have?
ScholarIQindexed works
Arthur I. Sagalowsky has 494 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Arthur I. Sagalowsky have?
ScholarIQcitation count
Arthur I. Sagalowsky has 19,797 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Arthur I. Sagalowsky?
ScholarIQh-index
Arthur I. Sagalowsky has an h-index of 74 in OpenAlex.
What is the i10-index of Arthur I. Sagalowsky?
ScholarIQi10-index
Arthur I. Sagalowsky has an i10-index of 230 in OpenAlex.
What is the ORCID of Arthur I. Sagalowsky?
ScholarIQorcid
The ORCID for Arthur I. Sagalowsky is on the source record.
What is the OpenAlex record for Arthur I. Sagalowsky?
ScholarIQopenalex
The OpenAlex for Arthur I. Sagalowsky is on the source record.
What are the most-cited papers on Arthur I. Sagalowsky?
ScholarIQmost cited works
BAP1 loss defines a new class of renal cell carcinoma
Samuel Peña‐Llopis, Silvia Vega-Rubín-de-Celis, Arnold Liao, Nan Leng, Andrea Pavía-Jiménez, Shanshan Wang, Toshinari Yamasaki, Leah Zhrebker, Sharanya Sivanand, Patrick Spence, Lisa N. Kinch, Tina Hambuch, Suneer Jain, Yair Lotan, Vitaly Margulis, Arthur I. Sagalowsky, Pia Banerji Summerour, Wareef Kabbani, SL Wong, Nick V. Grishin, Marc Laurent, Xian-Jin Xie, Christian Haudenschild, Mark T. Ross, David Bentley, Payal Kapur, James Brugarolas
A Validated Tumorgraft Model Reveals Activity of Dovitinib Against Renal Cell Carcinoma
Sharanya Sivanand, Samuel Peña‐Llopis, Hong Zhao, Blanka Kucejová, Patrick Spence, Andrea Pavía-Jiménez, Toshinari Yamasaki, David J. McBride, J. Gillen, Nicholas C. Wolff, Lorraine Morlock, Yair Lotan, Ganesh V. Raj, Arthur I. Sagalowsky, Vitaly Margulis, Jeffrey A. Cadeddu, Mark T. Ross, David Bentley, Wareef Kabbani, Xian-Jin Xie, Payal Kapur, Noelle S. Williams, James Brugarolas
NOMOGRAMS INCLUDING NUCLEAR MATRIX PROTEIN 22 FOR PREDICTION OF DISEASE RECURRENCE AND PROGRESSION IN PATIENTS WITH Ta, T1 OR CIS TRANSITIONAL CELL CARCINOMA OF THE BLADDER
Shahrokh F. Shariat, Craig D. Zippe, Gerson Lüdecke, Hans Boman, Marta Sänchez‐Carbayo, Roberto Casella, Christine Mian, Martin Friedrich, Sanaa Eissa, Hideyuki Akaza, Ihor Sawczuk, Vincenzo Serretta, Hartwig Huland, Hans Hedelin, Rupesh Raina, Naoto Miyanaga, Arthur I. Sagalowsky, Frank H. Wians, Claus G. Roehrborn, Yair Lotan, Paul Perrotte, Serge Benayoun, Michael Marberger, Pierre I. Karakiewicz
Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder
Pierre I. Karakiewicz, Serge Benayoun, Craig D. Zippe, Gerson Lüdecke, Hans Boman, Marta Sänchez‐Carbayo, Roberto Casella, Christine Mian, Martin Friedrich, Sanaa Eissa, Hideyuki Akaza, Hartwig Huland, Hans Hedelin, Rupesh Raina, Naoto Miyanaga, Arthur I. Sagalowsky, Michael Marberger, Shahrokh F. Shariat